Zinapar darinaparsin regulatory update

FDA granted Orphan Drug designation for Ziopharm's Zinapar darinaparsin to treat peripheral T cell lymphoma (PTCL). The company said it plans to "imminently" begin Phase I testing of the oral organic ...